Vanguard Global Advisers »

Avita Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $36k 9.7k 3.70

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Avita Therapeutics

OrbiMed Advisors
Vanguard Group
Vanguard Capital Management
BlackRock
Geode Capital Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Morgan Stanley
Bridgeway Capital Management
Divisadero Street Capital Management
Goldman Sachs Group
AQR Capital Management
Goss Wealth Management
Vanguard Portfolio Management

View all funds holding Avita Therapeutics